secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2025-04-24T23:59:59+00:00
Accession:  0000014272-25-000089
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bristol-Myers Squibb Q1 revenue $11.2B (-6% YoY), GAAP EPS $1.20, raises FY guidance
--------------------------------------------------------------------------------

- Total revenues $11.2B, down 6% (4% ex-FX) from $11.865B in Q1 2024.
- Growth Portfolio revenues $5.6B, up 16% (18% ex-FX) driven by new launches.
- GAAP EPS $1.20; non-GAAP EPS $1.80, compared to prior-year losses of $5.89 and $4.40 respectively.
- FY 2025 revenue guidance raised to ~$45.8B-$46.8B, non-GAAP EPS raised to $6.70-$7.00.
- CEO cites strong execution and pipeline progress; multi-year transformation plans on track.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000001427225000089/0000014272-25-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000001427225000089/bmy-20250424.htm
  HTML page:      https://secwatch.observer/filing/0000014272-25-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer